RT Journal Article
SR Electronic
A1 Hoyle, Brian
T1 CENTRIC Trial Results
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 6
SP 15
OP 16
DO 10.1177/155989771306009
UL http://mdc.sagepub.com/content/13/6/15.abstract
AB This article discusses the results of the multicenter, randomized, open-label, controlled, Phase 3 Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status study [CENTRIC; NCT00689221; J Clin Oncol 2013 (suppl; abstr LBA2009)].